ChrysCapital completed the acquisition of a 3% stake in Intas for $132m.

Synopsis

ChrysCapital, a private equity firm, completed the acquisition of a 3% stake in Intas Pharmaceuticals, a pharmaceutical company, from Capital International, a provider of investment management services, for $132m.

Principals

target

Intas Pharmaceuticals

bidder

Chryscapital Management Company

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.